LianBio to receive total upfront consideration of $350 millionLianBio Board of Directors to conduct strategic review of business SHANGHAI and PRINCETON, N.J., Oct. 24, 2023 (GLOBE NEWSWIRE) LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that the company has entered into an agreement with Bristol Myers Squibb (BMS), whereby BMS has obtained LianBio’s exclusive rights to develop and c
Boulder economy, while challenged, rides a wave of science – BizWest bizwest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizwest.com Daily Mail and Mail on Sunday newspapers.
Boulder’s economy faces significant challenges, including labor shortages, inflation, workforce training, lack of affordable housing and high vacancies in office space.
Laboratorios Farmaceuticos Rovi (OTCMKTS:LABFF – Get Free Report) and Fulcrum Therapeutics (NASDAQ:FULC – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings. Institutional and Insider Ownership 89.8% of Fulcrum […]
Lyell Immunopharma (NASDAQ:LYEL – Get Rating) and Fulcrum Therapeutics (NASDAQ:FULC – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, earnings, institutional ownership and valuation. Profitability This table compares Lyell Immunopharma and Fulcrum Therapeutics’ […]